Cancer
Reminder!
The tier level is assigned to the guideline, NOT to the specific search terms. For example, a Tier 1 guideline has at least one recommendation that meets criteria for Tier 1, but also could include tier 2 or 3 recommendations.
DO read the guidelines to find out about specific search terms.
DON’T rely on the overall tier classification of the guideline for the specified search terms.
See More FAQ
| Publication | Tier |
|---|---|
|
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Tischkowitz Marc et al. Genetics in medicine : official journal of the American College of Medical Genetics 2021 |
|
|
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Daly Mary B et al. Journal of the National Comprehensive Cancer Network : JNCCN 2021 Jan 19(1) 77-102 |
|
|
Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.
Sohal Davendra P S et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Aug 36(24) 2545-2556 |
|
|
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
Stoffel Elena M et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Nov JCO1801489 |
|
|
Local Coverage Determination (LCD) for BRCA1 and BRCA2 Genetic Testing (limited coverage in specific instances)
The Centers for Medicare & Medicaid Services (CMS) |
|
|
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Syngal Sapna et al. The American journal of gastroenterology 2015 Feb 110(2) 223-62; quiz 263 |
|